Informações:
Falhas:
ID
33043
Descrição
The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00699426
Link
https://clinicaltrials.gov/show/NCT00699426
Palavras-chave
Versões (1)
- 24/11/2018 24/11/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
24 de novembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes NCT00699426
Eligibility Type 2 Diabetes NCT00699426
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT00699426
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus, Non-Insulin-Dependent | Metformin | Sulfonylurea | Diet therapy
Item
type 2 diabetes (who criteria) treated with metformin and/or sulfonylureas or diet
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C0038766 (UMLS CUI [3])
C0012159 (UMLS CUI [4])
C0025598 (UMLS CUI [2])
C0038766 (UMLS CUI [3])
C0012159 (UMLS CUI [4])
Age
Item
males and females between 40 and 70 years
boolean
C0001779 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c between 6,0-10,0
boolean
C0474680 (UMLS CUI [1])
Diabetes Mellitus Duration
Item
diabetes duration > 1 year
boolean
C0011849 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Kidney Disease | Serum creatinine raised
Item
kidney disease (s-creatinine above the upper limit of normal range).
boolean
C0022658 (UMLS CUI [1])
C0700225 (UMLS CUI [2])
C0700225 (UMLS CUI [2])
Liver disease | Alanine aminotransferase increased
Item
liver disease (alat increase > 3 times the upper limit of the normal range of alat).
boolean
C0023895 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151905 (UMLS CUI [2])
High urine albumin levels
Item
macroalbuminuria (urinary albumin excretion of > 300 mg/day).
boolean
C1654921 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
heart failure(nyha class lll or lv)
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Symptoms Neuropathy Severe | Determine vibration perception threshold Biothesiometer
Item
severe neuropathy (symptoms + vibration perception threshold > 50 measured by biothesiometer.)
boolean
C1457887 (UMLS CUI [1,1])
C0442874 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C1736033 (UMLS CUI [2,1])
C0810485 (UMLS CUI [2,2])
C0442874 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C1736033 (UMLS CUI [2,1])
C0810485 (UMLS CUI [2,2])
Neutropenia | Neutrophil count | Anemia | Hemoglobin measurement | Gender
Item
neutropenia (neutrophil count<2.0x10/l) or anemia (hemoglobin<8mm for men or <7mm for women.
boolean
C0027947 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0002871 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
C0079399 (UMLS CUI [5])
C0200633 (UMLS CUI [2])
C0002871 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
C0079399 (UMLS CUI [5])
Alcohol abuse
Item
alcohol abuse
boolean
C0085762 (UMLS CUI [1])
Drug abuse
Item
drug abuse
boolean
C0013146 (UMLS CUI [1])
Organic disease Severe | Metabolic Disease Severe | Malignant Neoplasms
Item
severe organic or metabolic diseases including cancer
boolean
C0683324 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0025517 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0006826 (UMLS CUI [3])
C0205082 (UMLS CUI [1,2])
C0025517 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0006826 (UMLS CUI [3])
C-peptide measurement
Item
c-peptide< 0,3 pmol/l
boolean
C0202100 (UMLS CUI [1])
Drug Interactions
Item
medicine interaction
boolean
C0687133 (UMLS CUI [1])
Insulin regime
Item
treatment with insulin
boolean
C0557978 (UMLS CUI [1])
Proton Pump Inhibitors Ulcer | Pharmaceutical Preparations Ulcer
Item
ppi or other medications for ulcus diseases
boolean
C0358591 (UMLS CUI [1,1])
C0041582 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0041582 (UMLS CUI [2,2])
C0041582 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0041582 (UMLS CUI [2,2])
Warfarin | Coumarins
Item
treatment with warfarin or other coumarin derivations
boolean
C0043031 (UMLS CUI [1])
C0010207 (UMLS CUI [2])
C0010207 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Hypersensitivity Investigational New Drugs
Item
allergy to medication used in the study
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Study Subject Participation Status
Item
participants may not participate in another clinical intervention trial
boolean
C2348568 (UMLS CUI [1])